热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Alexa Fluor® 700 anti-mouse CD3 Antibody
产品名称：
Alexa Fluor® 700 anti-mouse CD3 Antibody
产品类别：
抗体
产品编号：
100215
产品应用：
100215
[价格]
规格 价格 库存
25µg ￥ 1128 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD3 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor? 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor? 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  2. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  2. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  3. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  4. Abdul-Careem MF, et al. 2012. PLoS One. 7:e32821. PubMed
  5. Wojno E, et al. 2011. J Immunol. 187:266. PubMed
  6. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  7. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  8. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  9. Fisher E, et al. 2021. Front Immunol. 11:602254. PubMed
  10. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  11. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  12. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  13. Toomer G, et al. 2022. Viruses. 14:. PubMed
  14. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  15. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  16. Zhang H, et al. 2020. Cancer Cell. 37(1):37-54.e9.. PubMed
  17. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  18. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  19. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  20. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  21. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  22. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  23. Jiang H, et al. 2021. Oncoimmunology. 10:1943180. PubMed
  24. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  25. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  26. Watanabe K, et al. 2018. JCI Insight. 3. PubMed
  27. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  28. Levescot A, et al. 2021. J Clin Invest. 131:. PubMed
  29. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
  30. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  31. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  32. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  33. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  34. Li Q, et al. 2019. Front Pharmacol. 10:786. PubMed
  35. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  36. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  37. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  38. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  39. Li A, et al. 2020. J Virol. 94:00:00. PubMed
  40. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  41. Kiniry BE, et al. 2018. J Immunol. 200:1876. PubMed
  42. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  43. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  44. Green WD, et al. 2022. J Leukoc Biol. 111:147. PubMed
  45. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  46. Mantilla-Rojas C, et al. 2022. Cancers (Basel). 14:. PubMed
  47. Bendtsen SK, et al. 2022. Oncoimmunology. 11:2026020. PubMed
  48. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  49. Bruder J, et al. 2017. Mol Ther Methods Clin Dev. 10.1016/j.omtm.2017.08.003. PubMed
  50. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  51. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  52. Moguche AO et al. 2017. Cell host & microbe. 21(6):695-706 . PubMed
  53. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  54. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  55. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  56. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  57. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  58. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  59. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  60. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  61. Agashe VV, et al. 2018. J Immunol. 201:772. PubMed
  62. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  63. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  64. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  65. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  66. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  67. Zaitseva M, et al. 2017. Antiviral Research. 10.1016/j.antiviral.2017.05.002. PubMed
  68. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
  69. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  70. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  71. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  72. Voeller J, et al. 2019. J Immunother Cancer. 0.530555556. PubMed
  73. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  74. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  75. Mykk?nen O, et al. 2014. PLoS One. 9:114790. PubMed
  76. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  77. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  78. S?wen P et al. 2018. eLife. 7 pii: e41258. PubMed
  79. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  80. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  81. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  82. Chavez JS, et al. 2022. Cells. 11:. PubMed
  83. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  84. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  85. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  86. Rezende RM, et al. 2019. J Immunol. 203:2621. PubMed
  87. Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
  88. Hendin HE, et al. 2022. NPJ Vaccines. 7:42. PubMed
  89. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  90. Samuelson DR, et al. 2021. Commun Biol. 4:997. PubMed
  91. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  92. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  93. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
RRID
AB_493696 (BioLegend Cat. No. 100215) AB_493697 (BioLegend Cat. No. 100216)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线